Biochips Market Growth, Demand and Challenges of the Key Industry Players 2024-32
                     Global Biochips Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A cc o r d i ng  t o  t h e  l a t e s t  r e p o r t  b y  I M A R C  Gr o u p ,  t i t l e d  " B i o c h i p s  M a r k e t :  G l o b a l  
I n d u s t r y  T re n d s ,  S h a re ,  S i z e ,  Gr o w th ,  O p p o r t u n i ty  an d  F o r e ca s t  2 0 2 4 -
20 3 2 , "  t h e  g l o b a l  b i o c h i p s  m a r ke t  s i z e  r e a c he d  U S $  1 9 . 6  B i l l i o n  i n  2 0 2 3 .
B i o c h i p s  a r e  m i n i a t u r i z ed  m e d i ca l  d e v i ce s  t ha t  a r e  u s e d  i n  m o l e c u l a r  l a b o r a to r i e s  to  
ca r r y  o u t  s e v e ra l  b i o ch e m i c a l  r e ac t i o n s  s i m u l t a n e o us l y .  T h e y  c a n  r a p i d l y  s c re e n  a  
Report nu m b e r  o f  b i o l o g i c a l  a n a l y te s  f o r  a n  a r r a y  o f  a p p l i c a t i on s ,  s u c h  a s  d i s ea s e  d i a g n o s i s  
an d  d e te c t i o n  o f  h az a r d o us  b i o l o g i ca l  a g en t s  i n  a  s y s t e m .  
Highlight and T he y  o f f e r  s ev e r a l  a d va n t a ge s ,  i n c l ud i n g  t he  a b i l i t y  t o  p e r f o r m  h i g h - t h r ou g h p u t  an a l y s i s ,  a l l o w i n g  r es e a r ch e r s  to  a n a l y z e  t h o u sa n d s  o f  s a mp l e s  i n  a  s h o r t  a mo u n t  o f  
t i m e ,  an d  a r e  a l s o  h i g h l y  s e ns i t i v e  a n d  s p e c i f i c ,  e n a b l i n g  th e  de t e c t i o n  o f  l o w  
Description co n c e n t ra t i o n s  o f  b i o mo l e c u l e s  w i t h  h i g h  a cc u r a cy .  T h ey  a r e  u t i l i z e d  t o  d e t e r m i ne  g e n e  ex p r e s s i on ,  d e t e c t  m u t a t i o n s ,  i d e n t i f y  p r o t e i n s ,  an d  sc r e e n  f o r  d r u g  c a nd i d a t e s .  
C on s e q ue n t l y ,  t he y  a r e  u se d  i n  a  v a r i e t y  o f  a p p l i ca t i o n s ,  s u c h  a s  g en o m i c s ,  
p r o t e o m i c s ,  a nd  d r u g  d i s c o v e ry .  T h e y  c a n  a l s o  b e  a d op t e d  i n  m e d i c a l  d i a gn o s t i c s ,  
i n c l u d i n g  de t e c t i n g  i n f ec t i o u s  d i s e a s es  o r  ca n c e r  b i o m ar k e r s .
R eq u e s t  f o r  a  P D F  sa m p le  o f  th i s  r ep o r t :  
h t t p s : / /w w w . i ma r c g r o u p . co m / b i o ch i p s - ma r k e t / r e q u es t s a mp l e
Report Description
G l o b a l  B i o c h i p s  M a r k e t  T r e n d s :
T h e  i n c r e a s i n g  p r e v a l e n c e  o f  c h r o n i c  d i s o r d e r s  a m o n g  t h e  m a s s e s  i s  d r i v i n g  t h e  g l o b a l  m a r k e t .  C o u p l e d  w i t h  t h i s ,  t h e  g r o w i n g  
c o n s u m e r  h e a l t h  c o n c e r n s  a b o u t  s e v e r a l  v i r a l  i n f e c t i o n s  a n d  i m m u n o l o g i c a l  d i s o r d e r s  a r e  p r o p e l l i n g  t h e  d e m a n d  f o r  b i o c h i p s  i n  n e w  
d r u g  d i s c o v e r y  a n d  d e v e l o p m e n t  a c t i v i t i e s .  M o r e o v e r ,  t h e  d e v e l o p m e n t  o f  a d v a n c e d  b i o c h i p  t e c h n o l o g i e s ,  s u c h  a s  m i c r o f l u i d i c s  a n d  
n a n o t e c h n o l o g y ,  h a s  l e d  t o  t h e  c r e a t i o n  o f  m o r e  s o p h i s t i c a t e d  a n d  e f f i c i e n t  b i o c h i p s  t h a t  c a n  p e r f o r m  a  w i d e  r a n g e  o f  d i a g n o s t i c  a n d  
r e s e a r c h  a p p l i c a t i o n s ,  w h i c h  i s  a u g m e n t i n g  t h e  m a r k e t .  A d d i t i o n a l l y ,  t h e  i n c r e a s i n g  d e m a n d  f o r  n o n - i n v a s i v e  d i a g n o s t i c  t o o l s  i s  
s u p p o r t i n g  t h e  d e m a n d  f o r  b i o c h i p s  s i n c e  t h e y  o f f e r  a  n o n - i n v a s i v e  w a y  t o  d i a g n o s e  d i s e a s e s ,  t h e r e b y  r e d u c i n g  t h e  r i s k s  a n d  c o s t s  
a s s o c i a t e d  w i t h  i n v a s i v e  d i a g n o s t i c  p r o c e d u r e s .  B e s i d e s ,  t h e  g o v e r n m e n t s  o f  s e v e r a l  c o u n t r i e s  a r e  h e a v i l y  i n v e s t i n g  i n  b i o c h i p  
r e s e a r c h  a n d  d e v e l o p m e n t  t o  a d v a n c e  h e a l t h c a r e  a n d  l i f e  s c i e n c e s  r e s e a r c h ,  w h i c h  i s  c r e a t i n g  a  p o s i t i v e  m a r k e t  o u t l o o k .  T h e  m a r k e t  i s  
f u r t h e r  d r i v e n  b y  t h e  w i d e s p r e a d  u t i l i z a t i o n  o f  b i o c h i p s  i n  a g r i c u l t u r e  t o  a n a l y z e  p l a n t  a n d  s o i l  s a m p l e s ,  a l l o w i n g  f o r  m o r e  p r e c i s e  a n d  
e f f i c i e n t  f a r m i n g  p r a c t i c e s .  I n  l i n e  w i t h  t h i s ,  t h e  e x t e n s i v e  a d o p t i o n  o f  b i o c h i p s  t o  m o n i t o r  e n v i r o n m e n t a l  c o n d i t i o n s  a n d  d e t e c t  
p o l l u t a n t s  i n  a i r ,  w a t e r ,  a n d  s o i l  i s  f u r t h e r  s t r e n g t h e n i n g  t h e  d e m a n d  w o r l d w i d e .  F u r t h e r m o r e ,  t h e  g r o w i n g  i n v e s t m e n t s  i n  t h e  h e a l t h c a r e  
s e c t o r  p e r t a i n i n g  t o  c a n c e r  g e n o m i c s ,  h u m a n  p r o t e o m e ,  a n d  D N A  a n a l y s i s  a r e  i m p a c t i n g  t h e  m a r k e t  f a v o r a b l y .
L o o k i n g  f o r w a r d ,  t h e  m a r k e t  i s  a n t i c i p a t e d  t o  r e a c h  a  v a l u e  o f  U S $  6 4 . 3  B i l l i o n  b y  2 0 3 2 ,  e x h i b i t i n g  a  g r o w t h  r a t e  ( C A G R )  o f  
1 3 . 7 %  d u r i n g  2 0 2 4 - 2 0 3 2 .
V i e w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w w w . i m a r c g r o u p . c o m / b i o c h i p s - m a r k e t
Breakup by Product Type:
• DNA Chip
• Protein Chip
• Lab-On-a-Chip
• Enzyme Chip
 
Breakup by Fabrication Technique:
Report • Microarray
Segmentation • Microfl uidic
Breakup by Analysis Method:
• Electrophores is
• Luminescence
• Mass Spectrometry
• Electr ical  Signals
• Magnetism
Breakup by Application:
• Molecular  Analys is
o Hybridizat ion
o Protein
o Immunological
o Biomolecules
o Biomarker
Report o Others
• Diagnosis
Segmentation
o Gene Diagnosis
o Oncology
o Infl ammatory
o Others
• Non-Bio logical  Usage
Breakup by End User:
• Pharmaceutical  and Biotechnology Companies
• Hospitals and Diagnostics Centers
• Academic and Research Insti tutes
• Others
Breakup by Region:
• North America
Report • Europe
Segmentation • Asia-Pacifi c
• Latin America
• Middle East and Afr ica
• Agi lent Technologies,  Inc.
• bioMérieux SA
• Bio-RAD Laboratories,  Inc.
Competitive •  CapitalBio Corporation
• Dynamic Biosensors GmbH
Landscape 
• EMD Mi l l ipore Corporation
with Key • Fluidigm Corporat ion
Players • I l lumina, Inc.
• Perkinelmer, Inc.
• Thermo Fisher Scient ifi c Inc.
How has the global biochips market performed so far, 
and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in 
the global biochips market? 
What is the impact of each driver, restraint, and 
opportunity on the global biochips market?
Key 
What are the key regional markets?
Questions 
Answered in Which countries represent the most attractive biochips market?
the Report What is the breakup of the market based on the product type?
Which is the most attractive product type in the 
Biochips market?
What is the breakup of the market based on the 
fabrication technique?
Which is the most attractive fabrication technique in 
the biochips market?
What is the breakup of the market based on the 
analysis method?
What is the breakup of the market based on the 
analysis method?
Which is the most attractive analysis method in the 
Biochips market?
Key 
What is the breakup of the market based on the 
Questions application?
Answered in Which is the most attractive application in the biochips market?
the Report What is the breakup of the market based on the end user?
Which is the most attractive end user in the biochips 
market?
What is the competitive structure of the global biochips 
market?
Who are the key players/companies in the global 
biochips market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  B i o c h i p s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t  T y p e
    6 . 1     D N A  C h i p
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     P r o t e i n  C h i p
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     L a b - O n - a - C h i p
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
       
    6 . 4     E n z y m e  C h i p
        6 . 4 . 1  M a r k e t  T r e n d s
        6 . 4 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  F a b r i c a t i o n  T e c h n i q u e
    7 . 1     M i c r o a r r a y
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     M i c r o f l u i d i c
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  A n a l y s i s  M e t h o d
    8 . 1     E l e c t r o p h o r e s i s
Table of         8 . 1 . 1  M a r k e t  T r e n d s        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     L u m i n e s c e n c e
        8 . 2 . 1  M a r k e t  T r e n d s
Contents         8 . 2 . 2  M a r k e t  F o r e c a s t    8 . 3     M a s s  S p e c t r o m e t r y
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
    8 . 4     E l e c t r i c a l  S i g n a l s
        8 . 4 . 1  M a r k e t  T r e n d s
        8 . 4 . 2  M a r k e t  F o r e c a s t
    8 . 5     M a g n e t i s m
        8 . 5 . 1  M a r k e t  T r e n d s
        8 . 5 . 2  M a r k e t  F o r e c a s t
9    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    9 . 1     M o l e c u l a r  A n a l y s i s
        9 . 1 . 1  H y b r i d i z a t i o n
           9 . 1 . 1 . 1  M a r k e t  T r e n d s
           9 . 1 . 1 . 2  M a r k e t  F o r e c a s t  
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / b i o ch ip s - m a r ke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: